Sarepta Therapeutics, Inc. Profile Avatar - Palmy Investing

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDY…

Biotechnology
US, Cambridge [HQ]

Resulting Ratios

15 Records · Starting from 2009
Loading...
End of SRPT's Analysis
CIK: 873303 CUSIP: 803607100 ISIN: US8036071004 LEI: - UEI: -
Secondary Listings
SRPT has no secondary listings inside our databases.